Literature DB >> 1110624

Metabolic effects of propranolol in thyrotoxicosis. I. Nitrogen, calcium, and hydroxyproline.

L P Georges, R P Santangelo, J F Mackin, J J Canary.   

Abstract

The effect of propranolol on the hypermetabolism of thyrotoxicosis was investigated in eight subjects with diffuse toxic goiter. After equilibration on a constant nitrogen, calcium, and hydroxproline intake, nitrogen balance was determined before and during propranolol therapy prior to subtotal thyroidectomy and compared to similar data obtained in seven of the patients following surgically induced euthyroidism. Propranolol administration was associated with clinical amelioration and a rapid, statistically significant, improvement in nitrogen retention. A slight additional improvement in retention was noted in the postoperative euthyroid state. Oxygen consumption, measured serially in four patients, was not significantly changed by propranolol. Urinary loss of calcium, phosphorus, and hydroxyproline was unaffected by propranolol, but excretion of these substances was sharply reduced in the subjects restudied postoperatively. These data offer a evidence of a previously unreported nitrogen sparing effect of oral propranolol during its short-term administration in thyrotoxic man.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1110624     DOI: 10.1016/0026-0495(75)90003-7

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  The clinical importance of the sympathetic nervous system in Graves' disease.

Authors:  D G McDevitt
Journal:  Ir J Med Sci       Date:  1977-11       Impact factor: 1.568

Review 2.  Calcium metabolism in thyroid disease.

Authors:  G Benker; N Breuer; R Windeck; D Reinwein
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

3.  Preliminary report on the use of propranolol in thyrotoxicosis: I. Effect on serum thyroxine, triiodothyronine and reverse triiodothyronine concentrations.

Authors:  G J Tevaarwerk; M H Malik; D Boyd
Journal:  Can Med Assoc J       Date:  1978-08-26       Impact factor: 8.262

4.  Oxygen consumption in patients with hyperthyroidism before and after treatment with beta-blockade versus thyrostatic treatment: a prospective randomized study.

Authors:  S Jansson; K Lie-Karlsen; O Stenqvist; U Körner; K Lundholm; L E Tisell
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

Review 5.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

6.  Comparison of propranolol and metoprolol in the management of hyperthyroidism.

Authors:  L E Murchison; J How; P D Bewsher
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.